AlphaCore Capital’s Sanofi SNY Stock Holding History

AlphaCore Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,938	Closed	-$675K	–	1474
2025 Q4	$675K	Sell	13,938 -1,296	-9%	-$64.2K	0.02%	526
2025 Q3	$719K	Buy	15,234 +12,423	+442%	+$600K	0.02%	373
2025 Q2	$136K	Buy	+2,811	New	+$144K	0.01%	661
2020 Q2	–	Sell	-654	Closed	-$29K	–	266
2020 Q1	$29K	Buy	+654	New	+$31.3K	0.02%	136

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AlphaCore Capital's SNY Position: Q1 2026 in Review

AlphaCore Capital sold out of Sanofi (SNY) in Q1 2026, closing a stake of 13,938 shares — an estimated $675K sold.

AlphaCore Capital first reported a position in SNY in Q1 2020 and held it in 4 quarters. The position peaked at $719K in Q3 2025. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

AlphaCore Capital reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
AlphaCore Capital sold 13,938 Sanofi shares in Q1 2026, an estimated $675K.
AlphaCore Capital first reported a position in Sanofi in Q1 2020 and held it in 4 quarters.
AlphaCore Capital's Sanofi position peaked at $719K in Q3 2025.
745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.